2025 HCPCS Code Q0180
Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen
TAGS: prescription chemotherapy exceed substitute regimen approved therapeutic complete dosage dolasetron| Short Description | Dolasetron mesylate oral |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Code Added Date | April 01, 1998 |
| HCPCS Action Effective Date | April 01, 1998 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- Q4156 - Neox 100 or clarix 100
- Q4157 - Revitalon 1 square cm
- Q4158 - Kerecis omega3, per sq cm
- Q4159 - Affinity1 square cm
- Q4160 - Nushield 1 square cm
- Q4161 - Bio-connekt per square cm
- Q4162 - Wndex flw, bioskn flw, 0.5cc
- Q4163 - Woundex, bioskin, per sq cm
- Q4164 - Helicoll, per square cm
- Q4165 - Keramatrix, kerasorb sq cm
- Q4166 - Cytal, per square centimeter
- Q4167 - Truskin, per sq centimeter
- Q4168 - Amnioband, 1 mg
- Q4169 - Artacent wound, per sq cm
- Q4170 - Cygnus, per sq cm
- Q4171 - Interfyl, 1 mg
- Q4172 - Puraply or puraply am
- Q4173 - Palingen or palingen xplus
- Q4174 - Palingen or promatrx
- Q4175 - Miroderm